Your browser doesn't support javascript.
loading
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Connor, Matthew P; Prathapa, Neeharika; Frey, Noelle V; Gill, Saar I; Hexner, Elizabeth O; Bruno, Ximena Jordan; Lai, Catherine E; Loren, Alison W; Luger, Selina M; Matthews, Andrew H; McCurdy, Shannon R; Perl, Alexander E; Porter, David L; Zeringue, Arlene; Oved, Joseph H; Olson, Timothy S; Pratz, Keith W; Babushok, Daria V.
Afiliação
  • Connor MP; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania. matthew.connor@pennmedicine.upenn.edu.
  • Prathapa N; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Frey NV; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Gill SI; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Hexner EO; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Bruno XJ; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Lai CE; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Loren AW; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Luger SM; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Matthews AH; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • McCurdy SR; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Perl AE; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Porter DL; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Zeringue A; Information Services, University of Pennsylvania.
  • Oved JH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia.
  • Olson TS; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA; Department of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia.
  • Pratz KW; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania.
  • Babushok DV; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia. daria.babushok@pennmedicine.upenn.edu.
Haematologica ; 109(8): 2732-2737, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38634143
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Aplástica Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Aplástica Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article